Lumida
/ASPI
⌘K
ASP Isotopes Inc

ASP Isotopes Inc

ASPI
$3.31USD-7.80%-0.28 today

MARKET CAP

507.5M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $4

52W RANGE

$3
$14

AI Summary

Stalk
TrimMedium

ASPI remains in a Stage 4 decline with lower highs and lower lows, trading below all key EMAs and near multi-month lows. Extreme oversold readings caution against immediate selling without a relief rally. We will await a pullback into the declining EMA band as a structurally appropriate supply zone before trimming positions.

  • Revenue 2025: $23.8M (+480% YoY) driven by radiopharmacy
  • Cash & equivalents $333M (liquidity score 1.05) funds expansions
  • YTD net loss $34.9M driven by 84% higher Opex
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2023FY 2024FY 2025TREND
Sales, Adj.$433,026$4.1M$23.8M
YoY %+857.0%+475.5%
P / Sales132.9x60.9x18.6x
EV / Sales134.7x56.3x16.5x
Gross Profit, Adj.$138,970$1.6M$3.4M
YoY %+1050.6%+112.9%
Margin %32.1%38.6%14.3%
EV / Gross Profit419.8x146.0x115.6x
EBITDA, Adj.$-16.0M$-25.9M$-58.0M
YoY %-213.9%-61.7%-124.1%
Margin %-3696.0%-624.6%-243.2%
EV / EBITDA-3.6x-9.0x-6.8x
EBIT$-16.0M$-26.4M$-59.9M
YoY %-214.6%-64.3%-127.3%
Margin %-3704.6%-636.0%-251.2%
EV / EBIT-3.6x-8.9x-6.6x
Net Income$-16.3M$-35.1M$-175.1M
YoY %-229.3%-115.6%-398.6%
Net Margin-3761.0%-847.3%-734.2%
EPS (GAAP)-$0.49-$0.63-$2.11
YoY %-172.2%-28.6%-234.9%